AEGON ASSET MANAGEMENT UK Plc grew its holdings in Kimberly-Clark Corporation (NASDAQ:KMB – Free Report) by 33.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 468,828 shares of the company’s stock after buying an additional 116,203 shares during the quarter. AEGON ASSET MANAGEMENT UK Plc’s holdings in Kimberly-Clark were worth $45,228,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Greatmark Investment Partners Inc. grew its holdings in Kimberly-Clark by 2.9% during the fourth quarter. Greatmark Investment Partners Inc. now owns 3,533 shares of the company’s stock worth $356,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund raised its position in Kimberly-Clark by 0.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 37,999 shares of the company’s stock worth $3,834,000 after acquiring an additional 100 shares in the last quarter. New Mexico Educational Retirement Board lifted its holdings in Kimberly-Clark by 0.7% in the fourth quarter. New Mexico Educational Retirement Board now owns 15,093 shares of the company’s stock valued at $1,523,000 after acquiring an additional 100 shares during the period. Core Wealth Partners LLC lifted its holdings in Kimberly-Clark by 2.6% in the fourth quarter. Core Wealth Partners LLC now owns 4,352 shares of the company’s stock valued at $439,000 after acquiring an additional 112 shares during the period. Finally, ORG Wealth Partners LLC boosted its position in shares of Kimberly-Clark by 15.2% during the 4th quarter. ORG Wealth Partners LLC now owns 864 shares of the company’s stock worth $87,000 after purchasing an additional 114 shares in the last quarter. 76.29% of the stock is currently owned by hedge funds and other institutional investors.
Kimberly-Clark Stock Performance
Shares of KMB stock opened at $102.56 on Friday. The stock has a fifty day moving average price of $98.48 and a 200 day moving average price of $100.80. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.55 and a current ratio of 0.77. The stock has a market cap of $34.04 billion, a PE ratio of 16.10, a P/E/G ratio of 4.60 and a beta of 0.28. Kimberly-Clark Corporation has a 1 year low of $92.42 and a 1 year high of $137.46.
Kimberly-Clark Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 2nd. Investors of record on Friday, June 5th will be given a $1.28 dividend. The ex-dividend date is Friday, June 5th. This represents a $5.12 annualized dividend and a dividend yield of 5.0%. Kimberly-Clark’s payout ratio is currently 80.38%.
Insider Transactions at Kimberly-Clark
In other Kimberly-Clark news, insider Katy Chen sold 1,596 shares of Kimberly-Clark stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $95.34, for a total transaction of $152,162.64. Following the completion of the transaction, the insider owned 8,362 shares in the company, valued at approximately $797,233.08. The trade was a 16.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, VP Andrew Scribner sold 4,095 shares of the company’s stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of $98.00, for a total transaction of $401,310.00. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 7,096 shares of company stock worth $689,687. 0.75% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
KMB has been the topic of a number of recent analyst reports. Zacks Research cut shares of Kimberly-Clark from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 3rd. Piper Sandler raised their price objective on shares of Kimberly-Clark from $115.00 to $121.00 and gave the company an “overweight” rating in a research note on Wednesday. Barclays decreased their price objective on shares of Kimberly-Clark from $105.00 to $99.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. UBS Group upped their target price on shares of Kimberly-Clark from $105.00 to $106.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Kimberly-Clark from $110.00 to $109.00 and set a “hold” rating for the company in a report on Monday, March 30th. Four equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $115.43.
Check Out Our Latest Research Report on Kimberly-Clark
About Kimberly-Clark
Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.
Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.
Read More
- Five stocks we like better than Kimberly-Clark
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
